ZLIRTLHEWY

ZLIRTLHEWY is a potent peptide CD47/SIRPα interaction inhibitor. ZLIRTLHEWY is promising for research of cancers[1].

Product Specifications

UNSPSC

12352209

Target

CD47

Related Pathways

Immunology/Inflammation

Field of Research

Cancer; Inflammation/Immunology

Smiles

O=C1CC[C@@H](C(N[C@@H](CC(C)C)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CCCNC(N)=N)C(N[C@@H]([C@H](O)C)C(N[C@@H](CC(C)C)C(N[C@@H](CC2=CNC=N2)C(N[C@@H](CCC(O)=O)C(N[C@@H](CC3=CNC4=CC=CC=C34)C(N[C@@H](CC5=CC=C(C=C5)O)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)N1

Molecular Formula

C64H92N16O16

Molecular Weight

1341.51

References & Citations

[1]Zheng S, et al. Biomimetic Design of Peptide Inhibitor to Block CD47/SIRPα Interactions. Langmuir. 2023 Dec 12;39 (49) :18101-18112.

Shipping Conditions

Room temperature

Scientific Category

Peptides

Clinical Information

No Development Reported

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

AM1619 2 OD, 4 OD, 50 OD

MIRacle™ hsa-miR-6127 miRNA Agomir/Antagomir

Ask

View Details

GE17-0851-01 30 / PCK

Disposable PD 10 Desalting Columns

Ask

View Details

NBP2-54521F 100 µL

Mouse Monoclonal EpCAM/TROP1 Antibody (rMOC-31) [FITC]

Ask

View Details